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What Are Core Outcome Sets and Why Are They
Useful?
Good clinical trial design requires researchers to specify in
advance, in the protocol, those outcomes to be measured. If
research has not been conducted to identify the most appropriate
clinical trial outcomes in a given condition, three problems may
impair the usefulness of the research in informing clinical practice.
Firstly, researchers can select outcomes that suit their needs, at the
expense of outcomes that are of most importance to patients or
clinicians [1–3]. Secondly, heterogenous selection and measure-
ment of outcomes in clinical trials can impair the ability to
synthesise results across studies in systematic reviews [4]. Thirdly,
in the absence of a set of outcomes that should be measured and
reported in all clinical trials in the same condition, it can be
difficult to ascertain, in the final publication, whether authors
report all results or only those that they find favourable [5,6].
As a result, the standardisation of outcomes for clinical trials has
been proposed as a solution to the problems of inappropriate and
non-uniform outcome selection [4,7] and reporting bias [5,8]. The
most notable work relating to outcome standardisation has been
conducted by the OMERACT (Outcome Measures in Rheuma-
tology) collaboration, which advocates the use of core outcome sets
designed using consensus techniques that are then measured and
reported in clinical trials in rheumatology [9]. However, such
initiatives are uncommon. In some specialties, such as paediatrics,
the number of conditions covered is low and the quality of existing
studies variable [10]. In addition, there is limited guidance in the
literature regarding the development of a core outcome set. This
paper aims to contribute to the methodology of determining which
outcomes to measure in clinical trials, or systematic reviews of
clinical trials.
The Delphi Technique as a Method of Developing
Core Outcome Sets
One method for reaching consensus around which outcomes to
measure is the Delphi technique, which comprises sequential
questionnaires answered anonymously by a panel of participants
with relevant expertise. After each questionnaire, the group
response is fed back to participants [11]. In terms of the overall
validity of the final consensus, this approach has advantages over
less structured methods of reaching consensus such as round-table
discussions. Participants in a Delphi study do not interact directly
with each other, so situations where the group is dominated by the
views of certain individuals can be avoided. When participants
consider whether to change their opinion or stick to their original
answers, after seeing the group response this decision is not
affected by the desire to be seen to agree with senior, overly vocal,
or domineering individuals. Improvements in global communica-
tion have made it feasible to use the Delphi technique to involve
geographically distant participants in larger numbers than are
traditionally used in studies employing face-to-face discussion, and
so it is also increasingly being used to reach consensus around
many topics in medicine, such as education, development of
clinical guidelines, and prioritisation of research topics.
There is little guidance for researchers who wish to use the
Delphi technique, even though aspects of its methodology can be
interpreted in a variety of ways. Most published work has provided
guidance based on authors’ experiences, rather than empirical
research or theoretical justification for the methodological
decisions made. One systematic review describes a variety of
consensus techniques used for designing clinical guidelines [12].
The authors highlighted important methodological decisions that
may affect the overall quality of the final consensus, such as the
types of participants involved, the questions they are asked, the
information they receive to inform their answers, the manner of
the interaction between them, and the way in which consensus is
agreed. These have also been variously highlighted as important
aspects of methodology in other commentaries about the Delphi
technique [13–15].
To our knowledge, there is no guidance related to methodo-
logical considerations or reporting for studies using the Delphi
technique to determine which outcomes or domains to measure in
clinical research studies. The objective of the systematic review
summarised below (and included in full in Text S1) was to
examine studies that used the Delphi technique for this purpose.
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Our recommendations from this review are then summarised to
help inform the conduct and reporting of future initiatives.
A Systematic Review of Studies That Have Used
the Delphi Technique to Identify Which Outcomes
to Measure in Clinical Trials
We searched Medline (no date restrictions) in January 2010 to
identify studies that used the Delphi technique to determine which
outcomes to measure in clinical trials or systematic reviews of
clinical trials. From each eligible study, the following methodo-
logical aspects were noted: the participants involved, the types of
questions asked, whether the study was completely anonymised,
whether non-responders in earlier rounds were included or
excluded from subsequent rounds, and the definition of consensus
used by the authors. We also evaluated the quality with which the
methods and results were reported. These assessments enabled us
to identify variations in the methods applied within these studies,
and areas of reporting quality that could be improved.
Of 656 abstracts, 20 full text articles were retrieved, of which
five were excluded because they aimed to identify outcomes for use
in clinical practice, and the authors did not state whether the
participants considered their use in clinical research studies. Many
of the 636 studies excluded on the basis of the abstract described
the use of the Delphi process to develop clinical guidelines and
educational curricula. Of 15 studies included in the review, eight
developed core outcome sets for rheumatological conditions.
Others identified outcomes for pain in children, degenerative
ataxia, gastro oesophageal reflux disease, infantile spasms,
maternity care, multiple sclerosis, and thyroid eye disease.
Studies varied in terms of group composition and the manner in
which the Delphi process was conducted. Participation in such
studies was dominated by researchers, with patients and families
seldom involved.
The reporting quality of studies also varied. Important
methodological aspects that were generally less well reported were
the information provided to participants at the start of the Delphi
process, the information fed back to participants after each round,
and the level of anonymity. A summary of the reporting quality of
Summary Points
N Studies that use the Delphi process for gaining
consensus around a core outcome set for clinical trials
should be of sufficiently high quality in order for their
recommendations to be considered valid.
N We report a systematic review of 15 studies that used
the Delphi technique for this purpose, in which we
identified variability in methodology and reporting.
N To improve the quality of studies that use the Delphi
process for developing core outcome sets, we recom-
mend that patients and clinicians be involved, research-
ers and facilitators avoid imposing their views on
participants, and attrition of participants be minimised.
N Methodological decisions should be clearly described in
the main publication in order to enable appraisal of the
study.
Table 1. Reporting quality of the 15 included studies.
Broad Aspect of Reporting
Specific Items for Which the Reporting
Quality Was Assessed
Studies in Which
Clearly Reported
Studies in Which Not
Clearly Reported N/A
Size and composition of the panel Number of participants 15 0 0
Types of participants (e.g., clinicians, patients) 15 0 0
Proportion of each type of participant 15 0 0
How participants were identified/sampled 14 1 0
Methodology of the Delphi process Administration of questionnaires (e.g., postal) 15 0 0
How items were generated for first questionnaire 14 1 0
What was asked in each round 15 0 0
Information provided to participants before
the first round
6 9 0
How the overall group response was fed
back to participants
8 7 0
Level of anonymity (total or quasi-anonymity) 4 11 0
A priori definition of ‘‘consensus’’ about
whether an outcome should be measured)
7 1 7a
Were non-responders invited to subsequent rounds 10 0 5b
Results Number of respondents to each round 14 1 0
Number who completed every round 11 4 0
Results for each outcome in each round 0 15 0
Group response for each outcome (final round) 8 7 0
Distribution of response for each outcome in
the final round
7 8 0
List of all outcomes that participants agreed
should be measured
8 0 7a
aReaching a final consensus was not the aim of the Delphi process, so a definition of consensus was not given.
bAll participants responded to each round, so no discussion was made regarding non-responders.
doi:10.1371/journal.pmed.1000393.t001
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the studies is shown in Table 1. Each of the items included in the
table had been highlighted, by one or more of the commentaries
mentioned earlier [13–15], as an important methodological
consideration when using the Delphi technique. We tailored the
statements so they were relevant for the Delphi process as a
method of developing consensus around a core outcome set.
Although an assessment of response rate to each round could be
made in 14/15 studies, it was only possible to accurately assess
attrition rates in 11/15 studies, which reported the proportion of
first round respondents who also completed the final round. Of
these, only six studies reported the proportion of participants who
completed every round in the Delphi process, from start to finish.
Only seven reports presented a measure and distribution of the
group opinion for each outcome listed in the final round. No study
reported the results, in each round, for every outcome that was
considered by the group.
Guidance about Using the Delphi Technique to
Determine Core Outcome Sets
Involve Clinicians and Patients
Informed clinical decisions can only be based on the results of
trials that have measured outcomes of importance to both
clinicians and patients. Initiatives to identify which outcomes to
measure in clinical trials, however, focus on the opinions of
researchers. This means that outcomes included in existing core
sets may be selected to serve the needs of researchers in academia
or industry, rather than considering how important they are to
patients.
Patients have a variety of perspectives about living with a
condition, which may differ from those of clinicians and
researchers. In one study, involvement of patients in the design
of a systematic review highlighted certain outcomes as being of
particular importance, but these had not been measured in any of
the included trials [16]. Research conducted within the OMER-
ACT group also suggests that clinicians and researchers may not
realise that certain outcomes are very important for patients [17].
The perspective of patients is now routinely incorporated into the
work conducted by OMERACT [18]. Another important
initiative, which actively promotes the involvement of patients
and families in identifying priorities in clinical research, is the
James Lind Alliance (http://www.lindalliance.org/). In a recent
systematic review, this group found a few examples of conditions
in which patients and clinicians have worked, together, to identify
important research questions [19], and we feel that similar
collaboration is necessary to develop core outcome sets. Deter-
mining which outcomes are important may be useful to groups
who aim to identify important research questions.
The opinions of different groups can be analysed either together
or separately. The use of multiple panels, each comprising a
different group [17], acknowledges that there may be differences
in opinion. If different groups with potentially conflicting views are
included in a single panel, they may not be equally represented in
the final consensus. This can happen either because the panel
includes more participants from a certain group, so the final
consensus is numerically dominated by their responses [20], or
because participants tailor their answers to agree with a group they
perceive to be more authoritative.
In studies that use a single panel, comprising a mixture of
participants, authors should report a measure of the distribution of
scores for each outcome considered in the final round. This is
because cut-off scores, used in most studies, do not describe how
strongly the minority feel, and so an apparent consensus could
actually be masking major disagreement within the group [13].
Begin by Asking Open Questions
So that researchers do not impose their views on participants
and thus introduce bias into the study, participants are
traditionally asked open questions in the first round of a Delphi
process. In the context of identifying which outcomes to measure
in clinical research studies, this means that participants should
suggest potential outcomes that they feel should be considered in
the Delphi process, without being prompted or guided by
facilitators, steering committees, or reviews of the literature. Most
studies we identified did not take this approach. It is not clear
whether providing a list to participants for initial consideration
may overstate the importance of outcomes that are favourable to
the researchers, rather than those which may be of more
importance to clinicians and patients. Outcomes measured in
previous clinical trials do not always reflect those deemed most
appropriate by all stakeholders [1,2,21].
Try to Minimise Attrition
People with minority opinions may be more likely to drop out of
studies that use the Delphi process, so attrition as rounds progress
can lead to overestimation of the degree of consensus in the final
results. Strategies to prevent attrition bias are to only invite people
who respond to a pre-Delphi invitation to participate in the first
round [22] or to list, in the publication, only those participants
who either completed the entire Delphi process, or agreed the final
consensus statement [23]. An example of a paragraph that could
be used to explain to participants the importance of completing
the whole Delphi process is shown in Box 1.
Report Certain Aspects of the Methodology and Results
In order to enable appraisal of the quality of studies that use the
Delphi process to identify outcomes that should be measured in
clinical research, which may in turn affect whether the
recommendations are implemented, authors should describe
certain important methodological features in the study report.
Criticisms of the Delphi technique are that ‘‘expertise’’ of the
panel is arbitrarily defined, and that the validity of the final
consensus is questionable because individual participants are not
accountable for their responses, and they may be led towards
conformity with the group, rather than consensus of true opinions
[24]. As described earlier, attrition of participants may mean the
degree of consensus reached in the final round is overestimated
[25]. A recommended checklist of study characteristics and results
that should be reported in all studies that use the Delphi technique
to determine which outcomes to measure in clinical research
studies is shown in Table 2. Given the variation across previous
studies, it would be helpful if authors explained their methodo-
logical choices, and discussed the effects these may have on the
results.
Box 1. Example Text to Emphasize to
Participants the Importance of Completing
the Whole Delphi Process
Thank you for agreeing to participate in our study. It is very
important that you complete the questionnaires in each
round. The reliability of the results could be compromised
if people drop out of the study before it is completed,
because they feel that the rest of the group does not share
their opinions. If people drop out because they feel their
opinions are in the minority, the final results will
overestimate how much the sample of participants agreed
on this topic.
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Determining How to Measure the Outcomes
Included in the Core Set
Following the determination of which outcomes to include in a
core set, guidance is then required as to how to measure them.
One established method for doing so is the OMERACT
approach. Once core outcomes are agreed upon, potential
instruments to measure them are identified. The psychometric
properties of these instruments are then reviewed in terms of
feasibility, validity, and responsiveness before the preferred
instruments are agreed [9]. A more detailed review of the possible
approaches to this question of how to measure the chosen
outcomes is beyond the scope of this paper.
Future Areas of Methodological Research
Given variations in methodology between studies, we feel there
is a need for research to determine how best to develop core
outcome sets. An agenda for this research could be designed
through the COMET Initiative (Core Outcome Measures for
Effectiveness Trials), which is an international network of
individuals and organisations with interest or experience in the
development, application, and promotion of core outcome sets
(http://www.liv.ac.uk/nwhtmr/comet/comet.htm). One such ar-
ea of ongoing research and discussion relates to whether core
outcome sets designed for clinical practice, such as those developed
in the five studies we excluded, should be the same as those
designed for research. Another priority is research to identify the
most effective ways to incorporate the views of different groups of
participants, especially patients, in the design of core outcome
sets.
Supporting Information
Text S1 Full report (and PRISMA checklist) of the systematic
review of studies that used the Delphi technique to determine
which outcomes to measure in clinical trials.
Found at: doi:10.1371/journal.pmed.1000393.s001 (0.87 MB
DOC)
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Table 2. Recommended checklist that should be reported in studies using the Delphi technique to determine which outcomes to
measure in clinical trials or systematic reviews.
Size and Composition of the Panel
The total number of participants invited, and the number who completed the first round
Whether the following types of participants were involved in the study: clinicians (and whether they were eligible on the basis of treating patients with the condition of
interest, or whether clinical trial involvement was an additional requirement), patients or their families, researchers, biostatisticians, representatives from the
pharmaceutical industry, representatives from drug regulatory authorities, or other types of participants.
The proportion of each type of participant described above
How participants were identified/sampled
Methodology of the Delphi Process
Administration of questionnaires: postal, email, Internet, in person (e.g., at a clinic), or at a meeting
Information about outcomes, known to the facilitators before the study, which was provided to participants before the first round: e.g., if the Delphi process followed a
review of outcomes measured in clinical trials, were the results of the review shared with participants? Alternatively, if some work had been conducted prior to the
Delphi (e.g., workshop meeting, or focus groups amongst patients), were the results presented to the participants?
How outcomes were considered in the first questionnaire: were participants asked an open question i.e., no outcomes were initially listed, or were they asked to
comment on a pre-specified list? If the latter, was the source of the list identified? Where possible, the questions asked to participants should be described in the
methods, or made available to the reader, as supplementary information.
What was asked in subsequent rounds: where possible, the questions asked to participants should be described in the methods, or made available to the reader, as
supplementary information
Feedback to participants after each round: if the results were not fed back, but only certain outcomes were carried forward to the next round (e.g., only those suggested
by at least 10% were carried forward), this should be clearly described
Level of anonymity should be described: In order to be ‘‘fully anonymised’’, participants should not know the identities of the other individuals in the group, nor should
they know the specific answers that any other individual gave. In studies that are ‘‘quasi-anonymised’’, the participants know the identities of some or all of the other
individuals, but do not know how they individually responded to any of the questions in any round. In studies that are not anonymised, participants know the identity
of some or all of the other individuals, and also know how some or all of them responded to any of the questions in any round.
If a pre-determined definition of consensus was used, this should be clearly described in the methods section of the study report
Were non-responders invited to subsequent rounds, or were they excluded from the rest of the study? Were additional people invited as the Delphi progressed?
Results
Number of participants invited to each round
Number who completed every round
Results for each outcome scored by participants in each round: a measure of group response, preferably with a measure of distribution. If these data cannot be included
in the publication, even as a supplementary file, it should be made available on request.
Measure of group response for each outcome scored by participants in the final round
Distribution of response for each outcome scored by participants in the final round
A comprehensive list of all the outcomes that participants agreed should be included in the core set
doi:10.1371/journal.pmed.1000393.t002
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